Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
| Autor: | Ruobao Li, Zhong Lu, Yan Huang, Bolin Wang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Aging
medicine.medical_specialty Pneumonia Viral Disease Cochrane Library Risk Assessment Liver disease Diabetes mellitus Internal medicine medicine Humans Pandemics risk COPD business.industry COVID-19 Cell Biology medicine.disease Comorbidity meta-analysis comorbidity Meta-analysis business Risk assessment Coronavirus Infections Research Paper |
| Zdroj: | Aging (Albany NY) |
| ISSN: | 1945-4589 |
| Popis: | Currently, the number of patients with coronavirus disease 2019 (COVID-19) has increased rapidly, but relationship between comorbidity and patients with COVID-19 still not clear. The aim was to explore whether the presence of common comorbidities increases COVID-19 patients' risk. A literature search was performed using the electronic platforms (PubMed, Cochrane Library, Embase, and other databases) to obtain relevant research studies published up to March 1, 2020. Relevant data of research endpoints in each study were extracted and merged. All data analysis was performed using Stata12.0 software. A total of 1558 patients with COVID-19 in 6 studies were enrolled in our meta-analysis eventually. Hypertension (OR: 2.29, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|